Skip to content

EFFECTS OF MANIPULATION WITH MOVEMENT, MUSCLE ENERGY TECHNIQUE AND PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION (PNF) STRETCHING IN PATIENTS WITH KNEE OSTEOARTHRITIS A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL

EFFECTS OF MANIPULATION WITH MOVEMENT, MUSCLE ENERGY TECHNIQUE AND PROPRIOCEPTIVE NEUROMUSCULAR FACILITATION (PNF) STRETCHING IN PATIENTS WITH KNEE OSTEOARTHRITIS A DOUBLE-BLIND RANDOMIZED CONTROL TRIAL

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20231117001
Enrollment
80
Registered
2023-11-17
Start date
2023-03-14
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis (OA) is a common type of complex peripheral joint disorder with multiple risk factors and progressive that causes pain, joint limitation and functional limitations, increased utilization of health services and high economic costs to society. knee OA, pain, range of motion, quality of life, manipulation with movement, muscle energy technique, proprioceptive neuromuscular facilitation

Interventions

The MWM applies gliding of the tibia when doing knee flexion and extension in sustained medial, lateral, anterior, posterior or rotation, The therapist tests the gliding in all plane directions in the
infra red and tens
MWM,MET,PNF ,standard care

Sponsors

Doctoral Research Grant, Universitas Muhammadiyah Surakarta, Indonesia
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) being diagnosed with knee OA in grade 2 or more by the Kellgren and Lawrence classification, (2) aged 60 years old or more, (3)Having bilateral knee OA, (4) having knee pain > 3 by NRS, (5) able to walk 6 meters and using or not assisted devices.

Exclusion criteria

Exclusion criteria: (1) surgery in knee or lower extremity, (2) received an intraarticular corticosteroid or injection of hyaluronic acid in past 6 months, (3) Consume oral corticosteroid in past 4 weeks, (4) neurological disorders (stroke, parkinson, cerebral ataxia), (5) hypersensitivity around their knee, (6) can not understand the verbal command, (7) Complain low back pain associated with knee pain and (8) have some contraindications to do manual therapy, such as tumour, infection and dislocation, systemic disease, fracture, vertigo and spinal stenosis.

Design outcomes

Primary

MeasureTime frame
Pain before treatment and 4 weeks after end of treatment Numeric Rating Scale,Knee Range of Motion before treatment and 4 weeks after end of treatment Goniometer ,Quality of Life before treatment and 4 weeks after end of treatment Womac questionnaire

Secondary

MeasureTime frame
Static Balance before treatment and 4 weeks after end of treatment Single Leg Stance test and Functional Reach test ,Dynamic balance before treatment and 4 weeks after end of treatment Timed Up and Go test ,Lower extremity muscle strength before treatment and 4 weeks after end of treatment Five time sit to stand test,Fear of Falling before treatment and 4 weeks after end of treatment Activities Balance Confidence-16

Countries

Indonesia

Contacts

Public ContactDwi Komalasari

Universitas Muhammadiyah Surakarta

drks133@ums.ac.id62271717417

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026